Over the past decade, there has been much written about the rise of antibiotic resistant pathogens and the growing numbers of serious healthcare-associated infections. Some statistics have put the total cost of healthcare-associated infections at around $35-$45 billion dollars1. Infections associated with MRSA have been estimated to cost about $3-$4 billion2 and ventilator-associated pneumonia costs another $3 billion3. The truth is that we really do not know the extent of the problem or the associated costs, and this in itself is a problem. Whatever the number, we can all agree that the costs of healthcare-associated infections are an enormous drain on the economy, and this is prior to factoring in any of the socio-economic multiplier effects of HAIs due to death, loss of employment, impact on families/companies etc.